Table 1.
Clinical characteristics of the study.
| Study group | Control group | P | |
|---|---|---|---|
| N (male/female) | 21 (13/8) | 30 (16/14) | |
| Age (ys) | 62.00 ± 5.93 | 59.23 ± 5.70 | 0.100 |
| Duration (ys) | 11.00 ± 3.70 | 10.03 ± 4.38 | 0.413 |
| BMI (kg/m2) | 23.74 ± 3.05 | 25.55 ± 3.70 | 0.088 |
| FBG (mmol/L) | 7.28 ± 1.98 | 7.24 ± 1.38 | 0.923 |
| HbA1c (%) | 8.60 ± 2.41 | 8.39 ± 1.36 | 0.691 |
| hs-CRP (mg/L) | 35.46 ± 43.05 | 0.89 ± 1.09 | <0.0001 |
| ESR (mm/h) | 67.81 ± 29.56 | 22.4 ± 10.45 | <0.0001 |
| Vitamin D level (ng/ml) | 11.21 ± 5.20 | 17.73 ± 3.20 | <0.0001 |
| TC (mmol/L) | 4.07 ± 1.40 | 4.51 ± 0.90 | 0.178 |
| TG (mmol/L) | 1.35 ± 0.69 | 1.79 ± 0.99 | 0.084 |
| HDL-C (mmol/L) | 0.90 ± 0.30 | 1.11 ± 0.27 | 0.015 |
| LDL-C (mmol/L) | 2.58 ± 0.97 | 2.82 ± 0.82 | 0.352 |